On NoticeOn Notice
← Bills

Therapeutic Goods (Charges) Amendment Bill 2026

Second Reading
16 November 2026 · 3 days agoExplanatory Memorandum →

Summary

The Therapeutic Goods Administration (TGA) charges for processing applications and registrations will change under amendments to the Therapeutic Goods Act 1989. Currently, the TGA sets fees for reviewing medicines, medical devices, and other therapeutic products, but this amendment adjusts how these charges are calculated or structured. This matters because it affects how much pharmaceutical companies and device manufacturers pay when seeking approval in Australia, potentially influencing the speed of product approvals and the costs passed on to healthcare systems and patients.

Bill Progress

Senate

First Reading

Second ReadingCurrent

Committee of the Whole

Third Reading

House of Representatives

First Reading

Second Reading

Consideration in Detail

Third Reading

Royal Assent

Royal Assent

What happens at this stage

The main debate on whether the chamber supports the broad purpose of the bill. Members speak to its overall merits and concerns rather than the fine print. The government outlines its policy intentions; the opposition and crossbench put their case. This is the stage that determines whether the bill proceeds at all.

Next: Consideration in Detail (House) or Committee of the Whole (Senate), where the bill is examined clause by clause